| Application no. and date | 03762054.9 (espacenet) (Federated) (European Patent Register), 20030625 | | Patent/reg. no. and date | DK/EP 1532127, 20060927 | | Publication date | 20050525 | | Priority no. and date | US 392677 P, 20020627 | | EP pub. no. and date |
EP 1532127 20050525 | | Effective date | | | Applicant/owner | SmithKline Beecham Corporation, One Franklin Plaza
P.O. Box 7929
Philadelphia, PA 19101, US | | Applicant ref. no. | P80601836DK00E | | Inventor | DOAN, Brian, Daniel
GlaxoSmithKline, 709 Swedeland Rd
King of Prussia, PA 19406, US,
PATTERSON, Daniel, Edward
GlaxoSmithKline, Five Moore Drive,
PO Box 13398
Research Triangle Park, NC 27709, US,
ROBERTS, John, C.
GlaxoSmithKline, Five Moore Drive,
PO Box 13398
Research Triangle Park, NC 27709, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | C07D 307/26 (2006.01) , C07D 493/04 (2006.01) | | Title | Fremstilling af stereoisomerer af (3alfa,3alfa/beta,6alfa/beta)hexahydrofuro(2,3-b)furan-3-ol | | Int. application no. | US2003020094 | | Int. publication no. | WO2004002975 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
